Discontinuation of Peritoneal Dialysis after Late Initiation of Eculizumab in a Case of Familial Atypical Hemolytic-Uremic Syndrome: A Case Report
Conclusions: This case shows that eculizumab treatment for patients with atypical hemolytic-uremic syndrome, even when initiated many months after beginning on dialysis, might offer substantial benefits and improve the patients ’ quality of life.Case Rep Nephrol Dial 2017;7:18 –25
Source: Case Reports in Nephrology and Dialysis - Category: Urology & Nephrology Source Type: research
More News: Anemia | Dialysis | Genetics | Hemolytic Uremic Syndrome (HUS) | Laboratory Medicine | Peritoneal Dialysis | Thrombocytopenia | Urology & Nephrology